Radiopharmaceutical-based Sensing and Monitoring Systems

Publication ID: 24-11857647_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Radiopharmaceutical-based Sensing and Monitoring Systems,” Published Technical Disclosure No. 24-11857647_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857647_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,647.

Summary of the Inventive Concept

The inventive concept leverages the stable radiopharmaceutical composition of tetrofosmin and its pharmaceutically acceptable salts to develop novel sensing and monitoring systems for various industries, including environmental monitoring, agricultural optimization, industrial process control, homeland security, and food safety inspection.

Background and Problem Solved

The original patent disclosed a stable radiopharmaceutical composition of tetrofosmin and its pharmaceutically acceptable salts for diagnostic purposes. However, this technology has broader applications beyond medical diagnostics. The inventive concept addresses the need for more effective and efficient sensing and monitoring systems in various industries, where the unique properties of the radiopharmaceutical composition can be leveraged to provide innovative solutions.

Detailed Description of the Inventive Concept

The inventive concept involves the development of systems, methods, and devices that utilize the radiopharmaceutical composition of tetrofosmin and its pharmaceutically acceptable salts to detect, track, and quantify various parameters in different industries. For example, in environmental monitoring, the radiopharmaceutical composition can be used to detect and track radioactive contaminants in soil and water samples. In agricultural optimization, the composition can be used to measure crop uptake of nutrients and pesticides, allowing for more targeted fertilizer and pesticide application. Similarly, in industrial process control, the composition can be used to monitor and regulate the concentration of radioactive isotopes in industrial processes.

Novelty and Inventive Step

The inventive concept is novel and non-obvious in its application of the radiopharmaceutical composition to entirely new industries and use cases, beyond medical diagnostics. The combination of the radiopharmaceutical composition with sensors, detectors, and other devices to create innovative sensing and monitoring systems is an inventive step that provides a new and useful solution to existing problems in these industries.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different radiopharmaceutical compositions, or the development of miniaturized sensors and detectors that can be integrated into existing systems. Variations of the inventive concept could also include the use of different detection methods, such as spectroscopy or chromatography, to quantify the parameters of interest.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including environmental monitoring, agricultural optimization, industrial process control, homeland security, and food safety inspection. The market for sensing and monitoring systems is growing rapidly, driven by increasing concerns about environmental sustainability, food safety, and national security. The inventive concept offers a new and innovative solution to these industries, with potential for significant revenue growth and market share.

CPC Classifications

SectionClassGroup
A A61 A61K51/0478
A A61 A61K9/19
A A61 A61K31/66
A A61 A61K51/025

Field of Art

Radiopharmaceutical composition and sensing technologies, specifically involving technetium-99m labeled compounds and their applications in diagnostic and monitoring systems

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in radiochemistry, nuclear medicine, or chemical engineering, possessing expertise in radioisotope labeling techniques, sensor design, and interdisciplinary applications of radiopharmaceutical compositions

Obviousness Rationale

A PHOSITA would recognize that the fundamental properties of the tetrofosmin radiopharmaceutical composition disclosed in the source patent inherently suggest broader applications beyond medical diagnostics. The stable chemical characteristics and precise labeling techniques naturally lend themselves to sensing and monitoring technologies across multiple industries. The extension of the radiopharmaceutical composition to environmental, agricultural, and industrial monitoring represents a predictable variation that would be obvious to a skilled practitioner familiar with radioisotope detection principles.

Obvious Combinations & Variations

Source Patent Element
Stable radiopharmaceutical composition with precise technetium-99m labeling
PTD Variation
Environmental monitoring sensor network using radiopharmaceutical detection principles
Obviousness Reasoning
Known techniques in radioisotope detection can be readily adapted to sensing applications, representing a predictable technological extension with finite solution set
Source Patent Element
Precise concentration and stability parameters for tetrofosmin composition
PTD Variation
Agricultural monitoring system measuring nutrient and pesticide uptake
Obviousness Reasoning
Quantitative measurement capabilities inherent in radiopharmaceutical compositions naturally suggest adaptation to scientific measurement across domains
Source Patent Element
Chemical stability parameters for radiopharmaceutical formulation
PTD Variation
Industrial process control detection system for radioactive isotope concentration
Obviousness Reasoning
Transferring measurement precision from medical diagnostics to industrial monitoring represents an obvious technological progression
Source Patent Element
Reconstitution methodology for maintaining radiochemical purity
PTD Variation
Homeland security detection network for tracking radioactive materials
Obviousness Reasoning
Established radioisotope detection principles can be directly applied to security screening with minimal inventive modification
Source Patent Element
Vial storage and oxygen content specifications
PTD Variation
Food safety inspection method for detecting radioactive contaminants
Obviousness Reasoning
Existing compositional stability techniques provide direct technological foundation for expanding detection applications
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857647, a person having ordinary skill in the art would find the proposed variations in radiopharmaceutical composition applications to be obvious extensions of the existing technological framework. The disclosed sensing and monitoring systems represent predictable variations that would be readily conceived by a skilled practitioner, thereby rendering potential claims in this domain obvious and unpatentable under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,647
TitlePharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof
Assignee(s)Jubilant Draximage Inc.